Read more: #Akums #DCGI #DiabeticNeuropathicPain #DiabetesCare #Neuropathy #PharmaInnovation #HealthcareInnovation #DrugDevelopment #PharmaIndustrialIndia To view or add a comment, sign in TLR4/MyD88/NF-B pathway A 2025 peer-reviewed study confirmed Guduchi suppresses this pathway in a vascular dementia model with effects comparable to both a pharmaceutical TLR4 inhibitor and donepezil
Malhotra A, Heilmann CR, Banerjee KK, Dunn JP, Bunck MC, Bednarik J
34, 15141531.e7
These symptoms can vary in severity and duration, impacting patients quality of life
A recent study published in JAMA Network Open has drawn attention to a possible, though rare, side effect: optic nerve disorders , specifically a condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
Legitimate manufacturers will investigate and often offer replacement product or a refund